CTRI/2022/01/039671Not yet recruitingPhase 3
â??A NON-RANDOMIZED SINGLE BLIND CLINICAL STUDY TO ASSESS THE EFFICACY OF BACH FLOWER REMEDIES IN MANAGEMENT OF GENERALISED ANXIETY DISORDER IN AGE GROUP OF ABOVE 18 YEARS.â??
Dr G V GAYATRI0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1)All the persons fulfilling the case definition given by ICD-10; DSM-5 criteria.
- •2)Persons having GAD-7 Score would be greater then or equal to 10.
- •3)Persons who are willing to take treatment regularly and co-operate for regular follow-ups.
- •4)Persons belonging to above 18 years age group.
Exclusion Criteria
- •1)Persons requiring IPD management.
- •2)BELOW 18 YEARS OF AGE.
- •3)Persons having GAD-7 Score would be lesser than 10.
- •4)Severely ill or emergency cases.
- •5)Persons presenting with gross pathological cases.
- •6)Persons suffering any systemic disorder which interfere with present study will be excluded.
- •7)Pregnant women and related disorders.
Investigators
Similar Trials
Not yet recruiting
Phase 3
A clinical trail to study the effectiveness of homoeopathic drugs in patient of acute and recurrent URTIs.CTRI/2021/05/033810I
Not yet recruiting
Phase 3
A clinical trial to study the effects of homoeopathic drugs in patients of age group 35-65 years with chronic Sleeplessness.CTRI/2021/05/033692il
Not yet recruiting
Phase 3
To study the effectiveness of homoeopathic drugs in patients with frozen shoulder.CTRI/2021/07/034959I
Not yet recruiting
Phase 3
A clinical trial to compare the homoeopathic drugs Natrum mur,Ignatia,Sepia,Graphitis in patients with mental symptoms in case of acute dermatitis.CTRI/2021/06/034123I
Completed
Not Applicable
The effect of Pegfilgrastim on treatment of anemia consequent taxans chemotherapy in breast cancer patientsCondition 1: Breast Cancer. Condition 2: Neutropenia.Malignant neoplasm of breast of unspecified siteNeutropeniaIRCT2017012121315N7CinnaGen Company75
